| Fluvirin |
103837 |
001 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
15UG/.5ML |
Pre-Filled Syringe |
1998/11/03
|
Seqirus Vaccines Limited |
Disc |
Licensed |
|
N/A |
| Enbrel |
103795 |
001 |
351(a) |
etanercept |
For Injection |
Subcutaneous |
25MG |
Single-Dose Vial |
1998/11/02
|
Immunex Corporation |
Disc |
Licensed |
N/A |
N/A |
| Verluma |
103769 |
001 |
351(a) |
nofetumomab |
Injection |
Intravenous |
10MG/ML |
|
1998/10/13
|
Boehringer Ingelheim Pharma GmbH & Co. KG |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Herceptin |
103792 |
001 |
351(a) |
trastuzumab |
For Injection |
Intravenous |
420MG |
Multi-Dose Vial |
1998/09/25
|
Genentech, Inc. |
Disc* |
Licensed |
N/A |
N/A |
| Remicade |
103772 |
001 |
351(a) |
infliximab |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
1998/08/24
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Humulin R U-100 |
018780 |
003 |
351(a) |
insulin human |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
1998/08/06
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Humalog |
020563 |
002 |
351(a) |
insulin lispro |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Multi-Dose Cartridge |
1998/08/06
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Infasurf |
020521 |
001 |
351(a) |
calfactant |
Suspension |
Intratracheal |
210MG/6ML (35MG/ML) |
Single-Dose Vial |
1998/07/01
|
ONY Biotech Inc. |
Rx |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
001 |
351(a) |
palivizumab |
For Injection |
Intramuscular |
50MG |
Single-Dose Vial |
1998/06/19
|
Swedish Orphan Biovitrum AB (publ) |
Disc |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
002 |
351(a) |
palivizumab |
For Injection |
Intramuscular |
100MG |
Single-Dose Vial |
1998/06/19
|
Swedish Orphan Biovitrum AB (publ) |
Disc |
Licensed |
N/A |
N/A |
| Simulect |
103764 |
001 |
351(a) |
basiliximab |
For Injection |
Intravenous |
20MG |
Single-Dose Vial |
1998/05/12
|
Novartis Pharmaceuticals Corporation |
Rx |
Licensed |
N/A |
N/A |
| Tisseel |
103980 |
001 |
351(a) |
Fibrin Sealant (Tisseel) |
For Solution |
Topical |
86.5 MG/ML Fibrinogen; 3000 KIU/ML Fibrinolysis Inh; 500 U/ML Thrombin |
Single-Dose Vial |
1998/05/01
|
Baxter Healthcare Corporation |
Rx |
Licensed |
|
N/A |
| Micrhogam, Rhogam |
103777 |
001 |
351(a) |
Rho(D) Immune Globulin (Human) |
Injection |
Intramuscular |
50UG |
Pre-Filled Syringe |
1998/04/23
|
Kedrion Biopharma Inc. |
Disc |
Licensed |
|
N/A |
| Micrhogam, Rhogam |
103777 |
002 |
351(a) |
Rho(D) Immune Globulin (Human) |
Injection |
Intramuscular |
300UG |
Pre-Filled Syringe |
1998/04/23
|
Kedrion Biopharma Inc. |
Rx |
Licensed |
|
N/A |
| Aplisol |
103782 |
001 |
351(a) |
Tuberculin, Purified Protein Derivative |
Injection |
Intradermal |
5TU/.1ML |
Multi-Dose Vial |
1998/04/20
|
Endo Operations Limited |
Rx |
Licensed |
|
N/A |
| Sucraid |
020772 |
001 |
351(a) |
sacrosidase |
Solution For Oral |
Oral |
1,003,000IU/118ML (8,500IU/ML) |
Bottle |
1998/04/09
|
QOL Medical, LLC |
Rx |
Licensed |
N/A |
N/A |
| Genotropin |
020280 |
003 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
0.6MG |
Pre-Filled Syringe |
1998/01/27
|
Pharmacia & Upjohn Company LLC |
Rx |
Licensed |
N/A |
N/A |
| Genotropin |
020280 |
004 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
0.2MG |
Pre-Filled Syringe |
1998/01/27
|
Pharmacia & Upjohn Company LLC |
Rx |
Licensed |
N/A |
N/A |
| Genotropin |
020280 |
005 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
0.8MG |
Pre-Filled Syringe |
1998/01/27
|
Pharmacia & Upjohn Company LLC |
Rx |
Licensed |
N/A |
N/A |
| Genotropin |
020280 |
006 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
0.4MG |
Pre-Filled Syringe |
1998/01/27
|
Pharmacia & Upjohn Company LLC |
Rx |
Licensed |
N/A |
N/A |